The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  November 2018 Next
  • 19th Meeting of the Spanish Society of Medicinal Chemistry “New challenges in Drug Discovery"

    July 8-11, 2019   Vitoria-Gasteiz, Spain

    The Spanish Society of Medicinal Chemistry (SEQT), member of the European Federation for Medicinal Chemistry (EFMC), welcomes you to the 18th meeting “New challenges in Drug Discovery”, to be held in Vitoria-Gasteiz on July 8-11, 2019.

    The scientific program will include both plenary and invited lectures, as well as short oral communications and flash poster presentations, covering different aspects of drug discovery and development.

    Invited Speakers:

    • José Ignacio Andrés (Janssen Cilag, Spain)
    • Gonçalo Bernardes (University of Cambridge, United Kingdom)
    • Erick M. Carreira (ETH Zürich, Switzerland)
    • Kristof van Emelen (ProDigest BVBA, Belgium)
    • Benoit Gauthier (CABIMER, Spain)
    • Yvette van Kooyk (University of Amsterdam, The Netherlands)
    • Luis M Liz- Marzán (CIC Biomagune, Spain)
    • Modesto J. Remuiñan (GSK, Spain)

    Deadline for abstract submission is April 5, 2019!

    Contact person: Francisco Palacios
    Tel: +34 945 01 31 03
    Fax: +34 945 01 30 14
    Email: francisco.palacios@ehu.eus

M T W T F S S
29 30 31 01 02 03 04
05 06 07 08 09 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 01 02
All events   |  Future events

Job portal

There are currently no jobs available

Job portal page

Follow us on Facebook

Follow us on Twitter

Follow us on LinkedIn

Follow us on Instagram

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRoche
 Prous Institute for Biomedical ResearchUCBJanssen R&DBayerMerck